These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 17541642)

  • 1. High-density single nucleotide polymorphism array analysis in patients with germline deletions of 22q11.2 and malignant rhabdoid tumor.
    Jackson EM; Shaikh TH; Gururangan S; Jones MC; Malkin D; Nikkel SM; Zuppan CW; Wainwright LM; Zhang F; Biegel JA
    Hum Genet; 2007 Sep; 122(2):117-27. PubMed ID: 17541642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic analysis using high-density single nucleotide polymorphism-based oligonucleotide arrays and multiplex ligation-dependent probe amplification provides a comprehensive analysis of INI1/SMARCB1 in malignant rhabdoid tumors.
    Jackson EM; Sievert AJ; Gai X; Hakonarson H; Judkins AR; Tooke L; Perin JC; Xie H; Shaikh TH; Biegel JA
    Clin Cancer Res; 2009 Mar; 15(6):1923-30. PubMed ID: 19276269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-resolution genomic analysis suggests the absence of recurrent genomic alterations other than SMARCB1 aberrations in atypical teratoid/rhabdoid tumors.
    Hasselblatt M; Isken S; Linge A; Eikmeier K; Jeibmann A; Oyen F; Nagel I; Richter J; Bartelheim K; Kordes U; Schneppenheim R; Frühwald M; Siebert R; Paulus W
    Genes Chromosomes Cancer; 2013 Feb; 52(2):185-90. PubMed ID: 23074045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors.
    Eaton KW; Tooke LS; Wainwright LM; Judkins AR; Biegel JA
    Pediatr Blood Cancer; 2011 Jan; 56(1):7-15. PubMed ID: 21108436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide approach to identify second gene targets for malignant rhabdoid tumors using high-density oligonucleotide microarrays.
    Takita J; Chen Y; Kato M; Ohki K; Sato Y; Ohta S; Sugita K; Nishimura R; Hoshino N; Seki M; Sanada M; Oka A; Hayashi Y; Ogawa S
    Cancer Sci; 2014 Mar; 105(3):258-64. PubMed ID: 24418192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors.
    Biegel JA; Tan L; Zhang F; Wainwright L; Russo P; Rorke LB
    Clin Cancer Res; 2002 Nov; 8(11):3461-7. PubMed ID: 12429635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of distal 22q11.2 deletion syndrome in a patient with a teratoid/rhabdoid tumour.
    Beddow RA; Smith M; Kidd A; Corbett R; Hunter AG
    Eur J Med Genet; 2011; 54(3):295-8. PubMed ID: 21187175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital anomalies and rhabdoid tumor associated with 22q11 germline deletion and somatic inactivation of the SMARCB1 tumor suppressor.
    Toth G; Zraly CB; Thomson TL; Jones C; Lapetino S; Muraskas J; Zhang J; Dingwall AK
    Genes Chromosomes Cancer; 2011 Jun; 50(6):379-88. PubMed ID: 21412926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SMARCB1 deletion by a complex three-way chromosomal translocation in an extrarenal malignant rhabdoid tumor.
    Bahrami A; Lee S; Caradine KD; Raimondi SC; Folpe AL
    Cancer Genet; 2014 Sep; 207(9):437-40. PubMed ID: 25312828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-linkage of familial rhabdoid tumors to SMARCB1 implies a second locus for the rhabdoid tumor predisposition syndrome.
    Frühwald MC; Hasselblatt M; Wirth S; Köhler G; Schneppenheim R; Subero JI; Siebert R; Kordes U; Jürgens H; Vormoor J
    Pediatr Blood Cancer; 2006 Sep; 47(3):273-8. PubMed ID: 16206192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel germ-line deletion of SNF5/INI1/SMARCB1 gene in neonate presenting with congenital malignant rhabdoid tumor of kidney and brain primitive neuroectodermal tumor.
    Kusafuka T; Miao J; Yoneda A; Kuroda S; Fukuzawa M
    Genes Chromosomes Cancer; 2004 Jun; 40(2):133-9. PubMed ID: 15101046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. hSNF5/INI1 inactivation is mainly associated with homozygous deletions and mitotic recombinations in rhabdoid tumors.
    Rousseau-Merck MF; Versteege I; Legrand I; Couturier J; Mairal A; Delattre O; Aurias A
    Cancer Res; 1999 Jul; 59(13):3152-6. PubMed ID: 10397258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrations of the hSNF5/INI1 gene are restricted to malignant rhabdoid tumors or atypical teratoid/rhabdoid tumors in pediatric solid tumors.
    Uno K; Takita J; Yokomori K; Tanaka Y; Ohta S; Shimada H; Gilles FH; Sugita K; Abe S; Sako M; Hashizume K; Hayashi Y
    Genes Chromosomes Cancer; 2002 May; 34(1):33-41. PubMed ID: 11921280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations.
    Sévenet N; Lellouch-Tubiana A; Schofield D; Hoang-Xuan K; Gessler M; Birnbaum D; Jeanpierre C; Jouvet A; Delattre O
    Hum Mol Genet; 1999 Dec; 8(13):2359-68. PubMed ID: 10556283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital extrarenal malignant rhabdoid tumor in an infant with distal 22q11.2 deletion syndrome: the importance of SMARCB1.
    Chakrapani AL; White CR; Korcheva V; White K; Lofgren S; Zonana J; Moore S; Krol A; Mansoor A
    Am J Dermatopathol; 2012 Aug; 34(6):e77-80. PubMed ID: 22814326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas.
    Modena P; Lualdi E; Facchinetti F; Galli L; Teixeira MR; Pilotti S; Sozzi G
    Cancer Res; 2005 May; 65(10):4012-9. PubMed ID: 15899790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Goldenhar phenotype in a child with distal 22q11.2 deletion and intracranial atypical teratoid rhabdoid tumor.
    Lafay-Cousin L; Payne E; Strother D; Chernos J; Chan M; Bernier FP
    Am J Med Genet A; 2009 Dec; 149A(12):2855-9. PubMed ID: 19938088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. INI1 expression is retained in composite rhabdoid tumors, including rhabdoid meningiomas.
    Perry A; Fuller CE; Judkins AR; Dehner LP; Biegel JA
    Mod Pathol; 2005 Jul; 18(7):951-8. PubMed ID: 15761491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translocation (1;22)(p36;q11.2) with concurrent del(22)(q11.2) resulted in homozygous deletion of SNF5/INI1 in a newly established cell line derived from extrarenal rhabdoid tumor.
    Misawa A; Hosoi H; Imoto I; Iehara T; Sugimoto T; Inazawa J
    J Hum Genet; 2004; 49(10):586-589. PubMed ID: 15378398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosome 22q deletions in atypical teratoid/rhabdoid tumors in adults.
    Raisanen J; Biegel JA; Hatanpaa KJ; Judkins A; White CL; Perry A
    Brain Pathol; 2005 Jan; 15(1):23-8. PubMed ID: 15779233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.